Skip to main content
Premium Trial:

Request an Annual Quote

Great Basin Receives 510(k) Clearance for C. difficile MDx Test

NEW YORK (GenomeWeb News) – Great Basin today announced it has received 510(k) clearance from the US Food and Drug Administration for its first molecular diagnostic test for Clostridium difficile.

The test is based on a technology that uses an integrated disposable cartridge containing all necessary reagents and runs on a benchtop analyzer. The goal, the Salt Lake City-based firm said, is to deliver assays that can be performed in a CLIA-rated waived or moderately complex laboratory at a lower cost than other molecular diagnostics.

Other firms that offer FDA-cleared molecular tests for C. difficile include Meridian Bioscience, Cepheid, and Gen-Probe through its Prodesse acquisition.

"Workflow matters, especially when diagnosing a difficult-to-treat and time-critical infection like C. diff," Great Basin President and CEO Ryan Ashton said in a statement. "The FDA's clearance of our C. diff assay will give healthcare providers access to a molecular test that improves workflow while providing answers at a cost that makes sense to the hospital."

He added that this year the company intends to augments its menu offering and to initiate clinical trials for a broad panel sepsis assay and a fungal pathogen assay.

Great Basin filed its FDA submission for the C. difficile in November.

The company said it also is launching its C. difficile test as a CE-IVD product in Europe and has begun marketing it in the European Union through local distributors.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.